Pediatric Respiratory Disease Treatment Market: Introduction
Rise in global pollution levels have caused the pediatric population to be highly susceptible to a number of respiratory ailments. Pediatric respiratory disorders and symptoms include aerodigestive disorders (recurrent aspiration), asthma, chronic cough, and congenital abnormalities of airway lung development including tracheobronchomalacia, cystic fibrosis, bronchopulmonary dysplasia (chronic lung disease), primary ciliary dyskinesia, recurrent respiratory infections pneumonia, respiratory failure ventilator dependency, sleep-apnea, and wheezing.
Read Report Overview -
https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=75423
Key Drivers and Restraints of Global Pediatric Respiratory Disease Treatment Market
Rise in prevalence of respiratory disorders, changing lifestyle habits, progressive increase in obese pediatric population, and surge in awareness about pediatric care are anticipated to increase expenditure on pediatric respiratory disease treatment
Allergic rhinitis is the most common form of non-infectious rhinitis. According to the International Study on Asthma and Allergies in Childhood (ISAAC), prevalence of rhinitis varies between 0.8% and 14.9% in six to seven-year old children and between 1.4% and 39.7% in 13 to 14-year old children. Countries with a very low prevalence include Indonesia, Albania, Romania, Georgia, and Greece. Countries with a very high prevalence include Australia, New Zealand, and the U.K.
Government and non-government organizations focus on campaigns to increase awareness about pediatric health. Several associations and foundations are playing an active role in spreading awareness about various pediatric conditions such as short bowel syndrome, neuroblastoma, leukemia, cancer palliative care, respiratory diseases care, mental health, and neonatal care.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=75423
The American Academy of Pediatrics (AAP), Substance Abuse and Mental Health Services Administration (SAMHSA), the Child Health and Development Institute (CHDI), the World Child Cancer, the Indian Cancer Society, and others are engaged in creating awareness among people about pediatric disorders
Asthma Segment to Lead Global Market
The global pediatric respiratory disease treatment market can be segmented based on drug class, disease type, distribution channel, and region
In terms of drug class, the global pediatric respiratory disease treatment market can be divided into anti-inflammatory drugs, bronchodilators, combination drugs, corticosteroid, monoclonal antibodies, and others. The combination drugs segment is expected to witness significant growth during the forecast period due to proven efficacy of these drugs in maintaining these conditions and promising pipeline of upcoming drugs in the segment.
Get COVID-19 Analysis on Pediatric Respiratory Disease Treatment Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19rep_id=75423
Based on disease type, the global pediatric respiratory disease treatment market can be classified into asthma, cystic fibrosis, bronchiolitis, pneumonia, idiopathic pulmonary fibrosis, tuberculosis, and others. According to recent global statistics by the Global Asthma Network, nearly 334 million people across the world are affected by asthma. Among them, 14% are children and 8.6% are young adults (aged between 18 and 45 years). Prevalence is higher in developed countries than developing ones.
In terms of distribution channel, the global pediatric respiratory disease treatment market can be classified into hospitals clinics, retail pharmacies, and online pharmacies
Asia Pacific to Offer Lucrative Opportunities in Global Pediatric Respiratory Disease Treatment Market
The global pediatric respiratory disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America is a significant market for pediatric respiratory disease treatment due to strong emphasis on health care development and high health care expenditure.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EBrep_id=75423
Asia Pacific is also anticipated to offer lucrative opportunities in the pediatric respiratory disease treatment market. This can be attributed to high patient population, rise in awareness about pediatric care, and increase in focus of public private organizations in preventing respiratory disorders in the developing countries.
Key Players Operating in Global Pediatric Respiratory Disease Treatment Market
Leading players in the global pediatric respiratory disease treatment market are:
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim GmbH
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Merck Co, Inc.
- Novartis AG
- Regeneron Pharmaceuticals
More Trending Reports by Transparency Market Research –
Trauma Implants Market:
In Vitro Diagnostics Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
